- Home
- RNR vs PCVX Comparison
RNR vs PCVX Comparison
Compare RNR & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNR
- PCVX
- Stock Information
- Founded
- RNR 1993
- PCVX 2013
- Country
- RNR Bermuda
- PCVX United States
- Employees
- RNR N/A
- PCVX N/A
- Industry
- RNR Property-Casualty Insurers
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- RNR Finance
- PCVX Health Care
- Exchange
- RNR Nasdaq
- PCVX Nasdaq
- Market Cap
- RNR 13.5B
- PCVX 13.2B
- IPO Year
- RNR 1995
- PCVX 2020
- Fundamental
- Price
- RNR $271.96
- PCVX $88.54
- Analyst Decision
- RNR Buy
- PCVX Strong Buy
- Analyst Count
- RNR 12
- PCVX 7
- Target Price
- RNR $289.50
- PCVX $147.50
- AVG Volume (30 Days)
- RNR 486.8K
- PCVX 1.6M
- Earning Date
- RNR 11-06-2024
- PCVX 11-05-2024
- Dividend Yield
- RNR 0.57%
- PCVX N/A
- EPS Growth
- RNR 127.60
- PCVX N/A
- EPS
- RNR 69.12
- PCVX N/A
- Revenue
- RNR $12,657,306,000.00
- PCVX N/A
- Revenue This Year
- RNR N/A
- PCVX N/A
- Revenue Next Year
- RNR $2.83
- PCVX N/A
- P/E Ratio
- RNR $3.94
- PCVX N/A
- Revenue Growth
- RNR 58.85
- PCVX N/A
- 52 Week Low
- RNR $188.24
- PCVX $48.24
- 52 Week High
- RNR $300.00
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- RNR 56.29
- PCVX 29.48
- Support Level
- RNR $262.70
- PCVX $85.18
- Resistance Level
- RNR $266.94
- PCVX $92.87
- Average True Range (ATR)
- RNR 8.11
- PCVX 5.42
- MACD
- RNR 0.39
- PCVX -1.35
- Stochastic Oscillator
- RNR 38.07
- PCVX 12.77
About RNR RenaissanceRe Holdings Ltd.
RenaissanceRe Holdings Ltd provides reinsurance and insurance solutions and related services. The company's core products include property, casualty and specialty reinsurance. Revenue is derived from three sources: net premiums earned from the insurance and insurance products sold; net investment income from the investment of capital funds and cash; and other income from the company's joint ventures, advisory services, and other items. The reportable segments of the company are the Property segment which includes catastrophe and other property reinsurance, and the Casualty and Specialty segment which is comprised of casualty and specialty reinsurance. It derives a majority of its revenue from the Casualty and specialty segment.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.